Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
William V Bobo, Richard C SheltonDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USAAbstract: Treatment-resistant depression (TRD) is a common occurrence in clinical practice. Up to 30% of patients with major depression do not respond to conventional a...
Enregistré dans:
Auteurs principaux: | William V Bobo, Richard C Shelton |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5fdafa09a7ea4ba58feb965b8086fa6d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
par: Luan S, et autres
Publié: (2017) -
Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
par: Zou C, et autres
Publié: (2013) -
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
par: Wang G, et autres
Publié: (2016) -
Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression
par: Santos T, et autres
Publié: (2012) -
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
par: Suzuki H, et autres
Publié: (2013)